Pacific Biosciences of California, Inc. (PACB) Total liabilities 2016–2025
Pacific Biosciences of California, Inc. (PACB) total liabilities at each fiscal year-end, per SEC filings.
$778.7MFY2025 · since FY2016: $53.2M → $778.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $778.7M | +3.3% |
| FY2024 | $753.9M | -27.8% |
| FY2023 | $1.0B | -13.2% |
| FY2022 | $1.2B | -1.0% |
| FY2021 | $1.2B | +1449.2% |
| FY2020 | $78.5M | -15.7% |
| FY2019 | $93.1M | +65.6% |
| FY2018 | $56.2M | -3.0% |
| FY2017 | $58.0M | +9.0% |
| FY2016 | $53.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice